We are live on ! Find out more
JPMIA

J.P. Marvel Investment Advisors Portfolio holdings

AUM $705M
1-Year Est. Return 43.01%
This Fund
S&P 500
This Quarter Est. Return
+11.99%
1 Year Est. Return
+43.01%
3 Year Est. Return
+140.86%
5 Year Est. Return
+213.54%
10 Year Est. Return
AUM
$346M
AUM Growth
+$33.7M
Cap. Flow
-$378K
Cap. Flow %
-0.11%
Top 10 Hldgs %
37.97%
Holding
84
New
6
Increased
17
Reduced
27
Closed
14

Top Buys

Rank Stock Value
1
GTT
GTT Communications, Inc.
GTT
+$8.46M
2
MSFT icon
Microsoft
MSFT
+$4.67M
3
NVDA icon
NVIDIA
NVDA
+$4.53M
4
BMY icon
Bristol-Myers Squibb
BMY
+$4.19M
5
HES
Hess
HES
+$1.32M

Sector Composition

Rank Sector Weight
1 Healthcare 25.99%
2 Technology 20.42%
3 Financials 14.68%
4 Communication Services 13.75%
5 Consumer Discretionary 6.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JPM icon
1
JPMorgan Chase
JPM
$947B
$18.4M 5.31%
131,653
-365
-0.3% -$46.8K
AAPL icon
2
Apple
AAPL
$4.95T
$16.4M 4.74%
223,248
-1,192
-0.5% -$76.7K
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$3.99T
$13.7M 3.97%
204,820
+700
+0.3% +$45.2K
TMO icon
4
Thermo Fisher Scientific
TMO
$208B
$13.3M 3.86%
41,080
-21
-0.1% -$6.37K
AMZN icon
5
Amazon
AMZN
$2.49T
$12.5M 3.61%
135,240
-29,560
-18% -$2.62M
V icon
6
Visa
V
$689B
$12M 3.46%
63,684
+28
+0% +$5.04K
GTT
7
DELISTED
GTT Communications, Inc.
GTT
$11.9M 3.43%
1,044,215
+1,010,265
+2,976% +$8.46M
BMY icon
8
Bristol-Myers Squibb
BMY
$128B
$11.6M 3.35%
180,390
+73,118
+68% +$4.19M
CSCO icon
9
Cisco
CSCO
$452B
$11.2M 3.23%
232,697
-31
-0% -$1.44K
MS icon
10
Morgan Stanley
MS
$337B
$10.5M 3.03%
204,990
+281
+0.1% +$13.3K
JNJ icon
11
Johnson & Johnson
JNJ
$641B
$10.4M 3.01%
71,436
-600
-0.8% -$81.4K
DIS icon
12
Walt Disney
DIS
$168B
$10.1M 2.91%
69,588
-57
-0.1% -$7.96K
PFE icon
13
Pfizer
PFE
$141B
$9.97M 2.88%
268,186
-11
-0% -$392
BAC icon
14
Bank of America
BAC
$436B
$9.78M 2.83%
277,680
+1,385
+0.5% +$44.8K
GLW icon
15
Corning
GLW
$123B
$7.52M 2.17%
258,374
-710
-0.3% -$20.6K
LLY icon
16
Eli Lilly
LLY
$1.07T
$7.51M 2.17%
57,154
AKAM icon
17
Akamai
AKAM
$16.4B
$7.29M 2.11%
84,402
+2
+0% +$175
RTX icon
18
RTX Corp
RTX
$294B
$6.96M 2.01%
73,874
+130
+0.2% +$11.8K
ABBV icon
19
AbbVie
ABBV
$454B
$6.69M 1.93%
75,598
+5
+0% +$415
MDT icon
20
Medtronic
MDT
$108B
$6.57M 1.9%
57,928
+18
+0% +$1.98K
EOG icon
21
EOG Resources
EOG
$74.7B
$6.53M 1.89%
77,944
-535
-0.7% -$39.2K
INTC icon
22
Intel
INTC
$462B
$6.49M 1.88%
108,488
+13,425
+14% +$751K
LEA icon
23
Lear
LEA
$7.26B
$6.29M 1.82%
45,825
+3,716
+9% +$460K
ABT icon
24
Abbott
ABT
$182B
$6.15M 1.78%
70,764
+28
+0% +$2.35K
AWK icon
25
American Water Works
AWK
$26.3B
$6.06M 1.75%
49,311
-60
-0.1% -$7.27K

Similar funds

J.P. Marvel Investment Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, J.P. Marvel Investment Advisors held 84 positions worth $346M, up 11% from $312M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

J.P. Marvel Investment Advisors's Q4 2019 filing shows 6 new, 17 increased, 27 reduced and 14 closed positions. Its largest new stake was Microsoft: 31,804 shares worth $5.01M. The largest sale was Celgene Corp, an estimated $6.05M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 26% a quarter earlier, followed by Technology and Financials.

  • J.P. Marvel Investment Advisors's largest Q4 2019 buy was Microsoft: 31,804 shares worth $5.01M.
  • J.P. Marvel Investment Advisors added most to GTT Communications, Inc. in Q4 2019, an estimated $8.46M increase.
  • J.P. Marvel Investment Advisors's biggest Q4 2019 reduction was Amazon, cutting an estimated $2.62M.
  • J.P. Marvel Investment Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $6.05M.
  • J.P. Marvel Investment Advisors's ten largest holdings make up 38% of its $346M portfolio in Q4 2019.
  • J.P. Marvel Investment Advisors opened 6 new positions and closed 14 in Q4 2019.
  • J.P. Marvel Investment Advisors's portfolio value rose 11% quarter-over-quarter to $346M.

Based on J.P. Marvel Investment Advisors's 13F filing for Q4 2019, filed 9 Sep 2021.